Prestrelski
Frank Prestrelski, Portland, OR US
Patent application number | Description | Published |
---|---|---|
20120300129 | SYSTEM AND METHOD FOR CONTROLLING AUDIO/VIDEO DATA STREAMS - An apparatus and method processes audio/video (AV) streams in an intelligent manner by determining whether at least one AV source and/or destination is coupled to an AV dongle that is coupled to a host-type device. An indication is provided to the host-type device to process an AV stream as if the AV dongle is not coupled to the host-type device if it is determined that the at least AV source and/or destination is not coupled to an AV dongle and if the AV dongle is coupled to a host-type device. If it is determined that at least one AV source and/or destination is coupled to the AV dongle, selecting a driver and selecting a priority table contained in the AV dongle for processing the AV stream based on priority information contained in the priority table. | 11-29-2012 |
Steven Prestrelski, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20110060310 | INTRACUTANEOUS INJECTION - The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated fours of injectable paste of slurry. | 03-10-2011 |
Steven Prestrelski, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20120046225 | STABLE GLUCAGON FORMULATIONS FOR THE TREATMENT OF HYPOGLYCEMIA - The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated form of injectable glucagon that is dissolved in a pharmaceutically acceptable carrier. | 02-23-2012 |
20120232001 | STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS - Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations. | 09-13-2012 |
20140171362 | STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS - Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations. | 06-19-2014 |
20140171364 | STABLE GLUCAGON FORMULATIONS FOR THE TREATMENT OF HYPOGLYCEMIA - The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated form of injectable glucagon that is dissolved in a pharmaceutically acceptable carrier. | 06-19-2014 |
20140179599 | STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS - Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations. | 06-26-2014 |
20140179600 | STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS - Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations. | 06-26-2014 |
20140349926 | FORMULATIONS FOR THE TREATMENT OF DIABETES - Disclosed is a formulation for parenteral administration comprising insulin that comprises a pH memory between 1 to 4 or between 6 to 8 and an aprotic polar solvent, wherein the insulin is solubilized in the aprotic polar solvent, wherein the solubilized insulin comprises stable monomeric or dimeric forms of insulin or mixtures thereof, and wherein the water content of the formulation is equal to or less than 15% w/v. | 11-27-2014 |
20140363492 | INTRACUTANEOUS INJECTION - The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated fours of injectable paste of slurry. | 12-11-2014 |
Steven J. Prestrelski, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20100173005 | MICROPARTICLE FORMULATIONS FOR SUSTAINED-RELEASE OF BIOACTIVE COMPOUNDS - A composition is provided for administration to a subject by way of a needleless syringe. The composition is formed from particles having a mean mass aerodynamic diameter of from 1 to 250 microns, and an envelope density of from 0.1 to 25 g/cm.sup.3, where the particles include a biologically active agent and a sustained-release material that controls release of the active agent to a subject following administration of the composition thereto. Methods for delivering a biologically active agent to a subject are also provided. | 07-08-2010 |
Steven J. Prestrelski, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080200383 | Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent - The present disclosure is directed to stable pharmaceutical formulations and uses thereof. | 08-21-2008 |
20140005135 | STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS | 01-02-2014 |
20140221288 | METHODS FOR RAPIDLY TREATING SEVERE HYPOGLYCEMIA - Disclosed is a method for treating or preventing hypoglycemia in a patient comprising administering an effective amount of a composition comprising a glucagon peptide which has been dried in a non-volatile buffer, and wherein the glucagon peptide has a pH memory that is about equal to the pH of the glucagon peptide in the non-volatile buffer, and an aprotic polar solvent, wherein the moisture content of the formulation is less than 5%, and wherein the dried glucagon peptide maintains the pH memory that is about equal to the pH of the glucagon peptide in the non-volatile buffer when the dried glucagon peptide is reconstituted in the aprotic polar solvent, wherein the patient has been diagnosed as having a blood glucose level between 0 mg/dL and less than 50 mg/dL or has an indication of impending hypoglycemia based on a blood glucose monitoring device before administration of the composition, and wherein the patient has a blood glucose level greater than 50 mg/dL to 180 mg/dL within 1 to 20 minutes after administration of the composition. | 08-07-2014 |